Biomarin Pharmaceutical Inc (BMRN) — Free Cash Flow Generation Index
Biomarin Pharmaceutical Inc (BMRN) has a Free Cash Flow Generation Index of 0.83x as of June 2026. Free cash flow of $139.29 Million represents 1% of operating cash flow ($168.11 Million). Explore capital reinvestment ratio of Biomarin Pharmaceutical Inc to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Biomarin Pharmaceutical Inc Free Cash Flow Generation Index (2009–2025)
Historical FCF Generation Index trend for Biomarin Pharmaceutical Inc across 12 annual periods. For the full cash flow conversion analysis, see how efficiently does Biomarin Pharmaceutical Inc generate cash.
Annual Free Cash Flow Generation for Biomarin Pharmaceutical Inc (2009–2025)
Year-by-year Free Cash Flow Generation Index for Biomarin Pharmaceutical Inc. Check Biomarin Pharmaceutical Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.88x | $724.96 Million | $827.99 Million | $103.04 Million | ▲ +5.5% |
| 2024 | 0.83x | $475.42 Million | $572.84 Million | $97.42 Million | ▲ +155.9% |
| 2023 | 0.32x | $51.65 Million | $159.26 Million | $107.61 Million | ▲ +3.8% |
| 2022 | 0.31x | $54.94 Million | $175.90 Million | $120.96 Million | ▼ -48.7% |
| 2021 | 0.61x | $185.31 Million | $304.54 Million | $119.22 Million | ▲ +199.6% |
| 2020 | -0.61x | $-52.15 Million | $85.36 Million | $137.52 Million | ▲ +69.5% |
| 2019 | -2.00x | $-96.76 Million | $48.26 Million | $145.03 Million | ▲ +67.4% |
| 2018 | -6.16x | $-124.41 Million | $20.21 Million | $144.62 Million | ▼ -302.1% |
| 2012 | -1.53x | $-26.96 Million | $17.61 Million | $44.57 Million | ▲ +78.8% |
| 2011 | -7.22x | $-135.47 Million | $18.75 Million | $154.22 Million | ▼ -340.9% |
| 2010 | -1.64x | $-30.71 Million | $18.75 Million | $49.46 Million | ▼ -6847.7% |
| 2009 | -0.02x | $-2.07 Million | $87.73 Million | $89.80 Million | — |